Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection

被引:374
作者
Pollicino, T
Squadrito, G
Cerenzia, G
Cacciola, I
Raffa, G
Craxì, A
Farinati, F
Missale, G
Smedile, A
Tiribelli, C
Villa, E
Raimondo, G [1 ]
机构
[1] Univ Messina Policlin, Unit Clin & Mol Hepatol, Dept Internal Med, I-98124 Messina, Italy
[2] Univ Palermo, Dept Gastroenterol, Palermo, Italy
[3] Univ Padua, Dept Gastroenterol, I-35100 Padua, Italy
[4] Hosp Parma, Div Infect Dis, Parma, Italy
[5] Univ Turin, Dept Gastroenterol, Turin, Italy
[6] Univ Trieste, Dept BBCM, Trieste, Italy
[7] Ctr Studi Fegato, Trieste, Italy
[8] Univ Modena, Dept Gastroenterol, I-41100 Modena, Italy
关键词
D O I
10.1053/j.gastro.2003.10.048
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Occult hepatitis B virus (HBV) infection is characterized by persistence of HBV DNA into the tissue of hepatitis B surface antigen-negative individuals. The clinical relevance of this peculiar infection is still under debate. In particular, the impact of occult HBV infection in cases of hepatocellular carcinoma (HCC) is uncertain. We investigated the prevalence and molecular status of occult HBV in patients with HCC. Methods: We tested tumor tissues from 107 patients with HCC and the corresponding nontumor liver tissue from 72 of these patients for HBV DNA. We also examined, liver specimens from :192 patients with chronic hepatitis. All cases were hepatitis B surface antigen negative. Covalently closed circular HBV genomes, HBV transcripts, and viral integrated forms were investigated in cases of HCC found positive for occult HBV. Results: Viral DNA was detected in 68 of 107 cases of HCC (63.5%) and in 63 of 192 cases of chronic hepatitis (32.8%) (P < 0.0001; odds ratio, 3.6; 95% confidence interval, 2.2-5.9). The significant association of occult HBV with HCC was irrespective of age, sex, and contemporary hepatitis C virus infection. Both integrated viral DNA and covalently closed circular HBV genomes were detected in patients with occult HBV. Moreover, the presence of free HBV genomes was associated with persistence of viral transcription and replication. Conclusions: Our findings provide clear evidence that occult HBV is a risk factor for development of HCC and show that the potential mechanisms whereby overt HBV might induce tumor formation are mostly maintained in cases of occult infection.
引用
收藏
页码:102 / 110
页数:9
相关论文
共 56 条
[1]  
BEASLEY RP, 1991, VIRAL HEPATITIS AND LIVER DISEASE, P532
[2]   Hepatocellular carcinoma [J].
Bergsland, EK ;
Venook, AP .
CURRENT OPINION IN ONCOLOGY, 2000, 12 (04) :357-361
[3]   Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation [J].
Bläckberg, J ;
Kidd-Ljunggren, K .
JOURNAL OF HEPATOLOGY, 2000, 33 (06) :992-997
[4]   Epidemiology of primary liver cancer [J].
Bosch, FX ;
Ribes, J ;
Borràs, J .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :271-285
[5]   Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen:: Clinically significant or purely "occult"? [J].
Bréchot, C ;
Thiers, V ;
Kremsdorf, D ;
Nalpas, B ;
Pol, S ;
Paterlini-Bréchot, P .
HEPATOLOGY, 2001, 34 (01) :194-203
[6]   STATE OF HEPATITIS-B VIRUS-DNA IN HEPATOCYTES OF PATIENTS WITH HEPATITIS-B SURFACE ANTIGEN-POSITIVE AND ANTIGEN-NEGATIVE LIVER-DISEASES [J].
BRECHOT, C ;
HADCHOUEL, M ;
SCOTTO, J ;
FONCK, M ;
POTET, F ;
VYAS, GN ;
TIOLLAIS, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (06) :3906-3910
[7]   Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) [J].
Bréchot, C ;
Gozuacik, D ;
Murakami, Y ;
Paterlini-Bréchot, P .
SEMINARS IN CANCER BIOLOGY, 2000, 10 (03) :211-231
[8]   Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[9]  
BUENDIA MA, 1994, SYMP SOC GEN MICROBI, V51, P173
[10]  
BUENDIA MA, 1995, DNA TUMOR VIRUSES ON, V6, P171